ELV VS SNY Stock Comparison

Performance

ELV
100/100

ELV returned -5.17% in the last 12 months. Based on SPY's performance of -12.93%, its performance is above average giving it a score of 100 of 100.

SNY
100/100

SNY returned 2.71% in the last 12 months. Based on SPY's performance of -13.91%, its performance is above average giving it a score of 100 of 100.

Technicals

ELV
61/100

ELV receives a 60 of 100 based on 14 indicators. 8 are bullish, 5 are bearish.

SNY
10/100

SNY receives a 10 of 100 based on 14 indicators. 0 are bullish, 12 are bearish.

Earnings

ELV
100/100

ELV has missed earnings 0 times in the last 20 quarters.

SNY
36/100

SNY has missed earnings 4 times in the last 20 quarters.

Profit

ELV
70/100

Out of the last 20 quarters, ELV has had 20 profitable quarters and has increased their profits year over year on 8 of them.

SNY
72/100

Out of the last 20 quarters, SNY has had 18 profitable quarters and has increased their profits year over year on 10 of them.

Volatility

ELV
42/100

ELV has had a lower than average amount of volatility over the last 12 months giving it a score of 41 of 100.

SNY
62/100

SNY has had a higher than average amount of volatility over the last 12 months giving it a score of 61 of 100.

Analyst Price Targets

ELV

"Analyst Price Targets" not found for ELV

SNY
83/100

3 analysts offer 12-month price targets for SNY. Together, they have an average target of 48.07, the most optimistic target put SNY at 48.07 within 12-months and the most pessimistic has SNY at 48.07.

All score calculations are broken down here to help you make more informed investing decisions

Elevance Health, Inc. Summary

New York Stock Exchange / ELV

Healthcare

Medical - Healthcare Plans

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Sanofi American Depositary Shares (Each representing one-half of one ordinary share) Summary

Nasdaq / SNY

Healthcare

Drug Manufacturers - General

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Power up your portfolio